Company profilePharmaceutical#279 of 1,318 in Pakistan2 DRAP alerts

ELKO ORGANIZATION (PVT) LTD.

Pharmaceutical company · 65 brands · 70 molecules

Ranked #28 of 32 companies in Antiinflammatory Agents And Antiinfectives In Combination

65 registered products 36 pharmaceutical brands 70 distinct molecules 2 DRAP alerts

Company overview

65
registered products
36
pharmaceutical brands
70
distinct molecules
7
therapeutic classes
2
DRAP alerts

ELKO ORGANIZATION (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 65 product registrations across 70 distinct molecules. Its portfolio is concentrated in Antiinflammatory Agents And Antiinfectives In Combination and Allergy. DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ELKO

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

4
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20253
20261

Top molecules by brand count

Therapeutic classes

Antiinflammatory Agents And Antiinfectives In Combination · 1Allergy · 1Other Beta-Lactam, Cephalosporins & Penems · 1Anti-Infectives · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Amphenicols · 1Antiinflammatory Agents, Corticosteroids · 1

Conditions treated

Nasal Congestion · 1General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official5 products · Rs 63.09 – Rs 462.07
DVAGO6 products · Rs 199.5 – Rs 636.5
Servaid6 products · Rs 108.9 – Rs 636
Median across source: Rs 370.48

Regulatory record

2 alerts in the DRAP feed we track.

16. Recall Alert (Human) – CDL Karachi declared substandard products.
2026-03-11
Recall Alert: Drug Product; Comycetin 0.5% Eye Drops (Batch # CYF003) by M/S. Nabiqasim In
2023-09-21

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 155 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
ENGLISH PHARMACEUTICALS INDUSTRIES holds 70 molecules not in this portfolio
000 I.UAmikacinAmoxicillinAmoxicillin BaseAmoxycillin BaseAmpicillin

Get the full profile for ELKO

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.